These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18346456)

  • 1. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.
    Kim MS; Lebron C; Nagpal JK; Chae YK; Chang X; Huang Y; Chuang T; Yamashita K; Trink B; Ratovitski EA; Califano JA; Sidransky D
    Biochem Biophys Res Commun; 2008 May; 370(1):38-43. PubMed ID: 18346456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.
    Kim MS; Chang X; Yamashita K; Nagpal JK; Baek JH; Wu G; Trink B; Ratovitski EA; Mori M; Sidransky D
    Oncogene; 2008 Jun; 27(25):3624-34. PubMed ID: 18223688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DFNA5 promoter methylation a marker for breast tumorigenesis.
    Croes L; de Beeck KO; Pauwels P; Vanden Berghe W; Peeters M; Fransen E; Van Camp G
    Oncotarget; 2017 May; 8(19):31948-31958. PubMed ID: 28404884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.
    Akino K; Toyota M; Suzuki H; Imai T; Maruyama R; Kusano M; Nishikawa N; Watanabe Y; Sasaki Y; Abe T; Yamamoto E; Tarasawa I; Sonoda T; Mori M; Imai K; Shinomura Y; Tokino T
    Cancer Sci; 2007 Jan; 98(1):88-95. PubMed ID: 17083569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
    Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
    Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
    Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer.
    Kikuchi M; Katoh H; Waraya M; Tanaka Y; Ishii S; Tanaka T; Nishizawa N; Yokoi K; Minatani N; Ema A; Kosaka Y; Tanino H; Yamashita K; Watanabe M
    Cancer Lett; 2017 Jan; 384():70-78. PubMed ID: 27756570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
    Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
    Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Wang BL; Chen L; Yang WT; Shen ZZ; Huang W; Shao ZM
    Hum Pathol; 2010 Jan; 41(1):48-58. PubMed ID: 19733895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
    Kong B; Lv ZD; Wang Y; Jin LY; Ding L; Yang ZC
    Int J Clin Exp Pathol; 2015; 8(9):11076-83. PubMed ID: 26617826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis.
    Chen L; Zhu Z; Sun X; Dong XY; Wei J; Gu F; Sun YL; Zhou J; Dong JT; Fu L
    Breast Cancer Res Treat; 2009 Aug; 116(3):471-8. PubMed ID: 18686028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.
    Zhou W; Jiang Z; Liu N; Xu F; Wen P; Liu Y; Zhong W; Song X; Chang X; Zhang X; Wei G; Yu J
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):91-102. PubMed ID: 18670789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
    Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
    Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.
    Pakneshan P; Têtu B; Rabbani SA
    Clin Cancer Res; 2004 May; 10(9):3035-41. PubMed ID: 15131040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
    Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
    Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
    Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
    OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.